Anxa9 gene expression in colorectal cancer: A novel marker for prognosis

Norikatsu Miyoshi, Hirofumi Yamamoto, Koshi Mimori, Shinya Yamashita, Susumu Miyazaki, Sumiko Nakagawa, Hideshi Ishii, Shingo Noura, Masayuki Ohue, Masahiko Yano, Yuichiro Doki, Masaki Mori

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Annexin A9 (ANXA9) is involved with the interaction with membrane phospholipids in a Ca2+-dependent manner. A previous study has shown that ANXA9 expression is associated with bone metastasis in breast cancer, whereas its significance in colorectal cancer (CRC) is unknown. The present study was comprised of 100 patients who underwent surgery for CRC. The correlation between gene expression and the clinical parameters of the patients was assessed. Patients with high ANXA9 expression were statistically susceptible to a relatively worse prognosis, and those with low ANXA9 expression showed improved overall survival compared with those with high expression. In conclusion, the present data suggests that ANXA9 expression is a prognostic factor in CRC patients.

Original languageEnglish
Pages (from-to)2313-2317
Number of pages5
JournalOncology Letters
Volume8
Issue number5
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Annexins
Colorectal Neoplasms
Gene Expression
Phospholipids
Breast Neoplasms
Neoplasm Metastasis
Bone and Bones
Membranes
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Anxa9 gene expression in colorectal cancer : A novel marker for prognosis. / Miyoshi, Norikatsu; Yamamoto, Hirofumi; Mimori, Koshi; Yamashita, Shinya; Miyazaki, Susumu; Nakagawa, Sumiko; Ishii, Hideshi; Noura, Shingo; Ohue, Masayuki; Yano, Masahiko; Doki, Yuichiro; Mori, Masaki.

In: Oncology Letters, Vol. 8, No. 5, 01.11.2014, p. 2313-2317.

Research output: Contribution to journalArticle

Miyoshi, N, Yamamoto, H, Mimori, K, Yamashita, S, Miyazaki, S, Nakagawa, S, Ishii, H, Noura, S, Ohue, M, Yano, M, Doki, Y & Mori, M 2014, 'Anxa9 gene expression in colorectal cancer: A novel marker for prognosis', Oncology Letters, vol. 8, no. 5, pp. 2313-2317. https://doi.org/10.3892/ol.2014.2477
Miyoshi N, Yamamoto H, Mimori K, Yamashita S, Miyazaki S, Nakagawa S et al. Anxa9 gene expression in colorectal cancer: A novel marker for prognosis. Oncology Letters. 2014 Nov 1;8(5):2313-2317. https://doi.org/10.3892/ol.2014.2477
Miyoshi, Norikatsu ; Yamamoto, Hirofumi ; Mimori, Koshi ; Yamashita, Shinya ; Miyazaki, Susumu ; Nakagawa, Sumiko ; Ishii, Hideshi ; Noura, Shingo ; Ohue, Masayuki ; Yano, Masahiko ; Doki, Yuichiro ; Mori, Masaki. / Anxa9 gene expression in colorectal cancer : A novel marker for prognosis. In: Oncology Letters. 2014 ; Vol. 8, No. 5. pp. 2313-2317.
@article{ce44a3a3136948fb86fd1e276b5400ad,
title = "Anxa9 gene expression in colorectal cancer: A novel marker for prognosis",
abstract = "Annexin A9 (ANXA9) is involved with the interaction with membrane phospholipids in a Ca2+-dependent manner. A previous study has shown that ANXA9 expression is associated with bone metastasis in breast cancer, whereas its significance in colorectal cancer (CRC) is unknown. The present study was comprised of 100 patients who underwent surgery for CRC. The correlation between gene expression and the clinical parameters of the patients was assessed. Patients with high ANXA9 expression were statistically susceptible to a relatively worse prognosis, and those with low ANXA9 expression showed improved overall survival compared with those with high expression. In conclusion, the present data suggests that ANXA9 expression is a prognostic factor in CRC patients.",
author = "Norikatsu Miyoshi and Hirofumi Yamamoto and Koshi Mimori and Shinya Yamashita and Susumu Miyazaki and Sumiko Nakagawa and Hideshi Ishii and Shingo Noura and Masayuki Ohue and Masahiko Yano and Yuichiro Doki and Masaki Mori",
year = "2014",
month = "11",
day = "1",
doi = "10.3892/ol.2014.2477",
language = "English",
volume = "8",
pages = "2313--2317",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Anxa9 gene expression in colorectal cancer

T2 - A novel marker for prognosis

AU - Miyoshi, Norikatsu

AU - Yamamoto, Hirofumi

AU - Mimori, Koshi

AU - Yamashita, Shinya

AU - Miyazaki, Susumu

AU - Nakagawa, Sumiko

AU - Ishii, Hideshi

AU - Noura, Shingo

AU - Ohue, Masayuki

AU - Yano, Masahiko

AU - Doki, Yuichiro

AU - Mori, Masaki

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Annexin A9 (ANXA9) is involved with the interaction with membrane phospholipids in a Ca2+-dependent manner. A previous study has shown that ANXA9 expression is associated with bone metastasis in breast cancer, whereas its significance in colorectal cancer (CRC) is unknown. The present study was comprised of 100 patients who underwent surgery for CRC. The correlation between gene expression and the clinical parameters of the patients was assessed. Patients with high ANXA9 expression were statistically susceptible to a relatively worse prognosis, and those with low ANXA9 expression showed improved overall survival compared with those with high expression. In conclusion, the present data suggests that ANXA9 expression is a prognostic factor in CRC patients.

AB - Annexin A9 (ANXA9) is involved with the interaction with membrane phospholipids in a Ca2+-dependent manner. A previous study has shown that ANXA9 expression is associated with bone metastasis in breast cancer, whereas its significance in colorectal cancer (CRC) is unknown. The present study was comprised of 100 patients who underwent surgery for CRC. The correlation between gene expression and the clinical parameters of the patients was assessed. Patients with high ANXA9 expression were statistically susceptible to a relatively worse prognosis, and those with low ANXA9 expression showed improved overall survival compared with those with high expression. In conclusion, the present data suggests that ANXA9 expression is a prognostic factor in CRC patients.

UR - http://www.scopus.com/inward/record.url?scp=84907153273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907153273&partnerID=8YFLogxK

U2 - 10.3892/ol.2014.2477

DO - 10.3892/ol.2014.2477

M3 - Article

AN - SCOPUS:84907153273

VL - 8

SP - 2313

EP - 2317

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 5

ER -